Elan reported fourth-quarter profit of $169.5 million, or 36 cents a share, as sales of multiple sclerosis drug Tysabri soared. More: continued here
Elan reported fourth-quarter profit of $169.5 million, or 36 cents a share, as sales of multiple sclerosis drug Tysabri soared. More: continued here
The software giant sees new opportunities in smartphone software, but some warn it faces unique hurdles in integrating software and hardware. More: continued here
The boards of Live Nation and Ticketmaster approved a merger of the two companies in a deal that would create an entertainment powerhouse, a report says. More: continued here
The Swiss bank reported a fourth-quarter loss of 8.1 billion Swiss francs ($6.9 billion) and a 2008 loss of 19.7 billion Swiss francs ($16.8 billion), and said its investment bank will cut its headcount to 15,000 by the end of 2009. More: continued here
Goldman Sachs moved a three-day conference to San Francisco from the Las Vegas Strip amid what the bank is calling a broad review of its activities. More: continued here
Investor Wilbur Ross and private equity group Carlyle are considering a joint bid for troubled bank BankUnited Financial, a report says. More: continued here
Cramer says to buy the stock on a pullback. More: continued here
The sale is a sign that credit markets may be easing as companies are increasingly able to find buyers for their bonds. More: continued here
Genentech’s request was well above Roche’s $89-a-share offer in July and one the Swiss pharmaceutical giant rejected as too expensive, documents filed by Roche say. More: continued here
The China Association of Automobile Manufacturers reports 735,000 vehicles were sold in China in January, surpassing the 656,976 vehicles sold in the U.S. market. More: continued here